{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:48:45Z","timestamp":1760550525655},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41434-017-0001-8","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:37:27Z","timestamp":1522809447000},"page":"198-204","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy"],"prefix":"10.1038","volume":"25","author":[{"given":"Wen-ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-ren","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-qiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-dong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,29]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","volume":"4","author":"BL Levine","year":"2017","unstructured":"Levine BL, Miskin J, Wonnacott K, Keir C. Global manufacturing of CAR T cell therapy. Mol Ther Methods Clin Dev. 2017;4:92\u2013101.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s11899-016-0336-z","volume":"11","author":"M Ruella","year":"2016","unstructured":"Ruella M, June CH. Chimeric antigen receptor T cells for B cell neoplasms: choose the right CAR for you. Curr Hematol Malig Rep. 2016;11:368\u201384.","journal-title":"Curr Hematol Malig Rep"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1189\/jlb.5BT1115-524R","volume":"100","author":"OO Oluwole","year":"2016","unstructured":"Oluwole OO, Davila ML. At the bedside: clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies. J Leukoc Biol. 2016;100:1265\u201372.","journal-title":"J Leukoc Biol"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-med-051914-021702","volume":"67","author":"CA Ramos","year":"2016","unstructured":"Ramos CA, Heslop HE, Brenner MK. CAR-T cell therapy for lymphoma. Annu Rev Med. 2016;67:165\u201383.","journal-title":"Annu Rev Med"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"e1027469","DOI":"10.1080\/2162402X.2015.1027469","volume":"4","author":"HR Dai","year":"2015","unstructured":"Dai HR, Zhang WY, Li SX, Han QW, Guo YL, Zhang Y, et al. Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia. Oncoimmunology. 2015;4:e1027469.","journal-title":"Oncoimmunology"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.clim.2014.10.002","volume":"155","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhang WY, Han QW, Liu Y, Dai HR, Guo YL, et al. Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells. Clin Immunol. 2014;155:160\u201375.","journal-title":"Clin Immunol"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-016-0357-z","volume":"9","author":"B Cai","year":"2016","unstructured":"Cai B, Guo M, Wang Y, Zhang Y, Yang J, Guo Y, et al. Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia. J Hematol Oncol. 2016;9:131.","journal-title":"J Hematol Oncol"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"224ra225","DOI":"10.1126\/scitranslmed.3008226","volume":"6","author":"ML Davila","year":"2014","unstructured":"Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014;6:224ra225.","journal-title":"Sci Transl Med"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/PPO.0000000000000035","volume":"20","author":"SL Maude","year":"2014","unstructured":"Maude SL, Barrett D, Teachey DT, Grupp SA. Managing cytokine release syndrome associated with novel T cell-engaging therapies. Cancer J. 2014;20:119\u201322.","journal-title":"Cancer J"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrc.2016.97","volume":"16","author":"AD Fesnak","year":"2016","unstructured":"Fesnak AD, June CH, Levine BL. Engineered T cells: the promise and challenges of cancer immunotherapy. Nat Rev Cancer. 2016;16:566\u201381.","journal-title":"Nat Rev Cancer"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1172\/JCI83092","volume":"126","author":"L Cherkassky","year":"2016","unstructured":"Cherkassky L, Morello A, Villena-Vargas J, Feng Y, Dimitrov DS, Jones DR, et al. Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition. J Clin Invest. 2016;126:3130\u201344.","journal-title":"J Clin Invest"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1084\/jem.20062319","volume":"204","author":"ML Ford","year":"2007","unstructured":"Ford ML, Koehn BH, Wagener ME, Jiang W, Gangappa S, Pearson TC, et al. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J Exp Med. 2007;204:299\u2013309.","journal-title":"J Exp Med"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0092-8674(81)90228-2","volume":"25","author":"HE Varmus","year":"1981","unstructured":"Varmus HE, Quintrell N, Ortiz S. Retroviruses as mutagens: insertion and excision of a nontransforming provirus alter expression of a resident transforming provirus. Cell. 1981;25:23\u201336.","journal-title":"Cell"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415\u20139.","journal-title":"Science"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.18632\/oncotarget.12387","volume":"8","author":"J Mani","year":"2017","unstructured":"Mani J, Wang L, Huckelhoven AG, Schmitt A, Gedvilaite A, Jin N, et al. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance. Oncotarget. 2017;8:2485\u20132500.","journal-title":"Oncotarget"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1182\/blood-2006-06-029173","volume":"109","author":"C Hsu","year":"2007","unstructured":"Hsu C, Jones SA, Cohen CJ, Zheng Z, Kerstann K, Zhou J, et al. Cytokine-independent growth and clonal expansion of a primary human CD8+T-cell clone following retroviral transduction with the IL-15 gene. Blood. 2007;109:5168\u201377.","journal-title":"Blood"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcyt.2014.04.003","volume":"16","author":"J Mani","year":"2014","unstructured":"Mani J, Jin N, Schmitt M. Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation. Cytotherapy. 2014;16:1325\u201335.","journal-title":"Cytotherapy"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","volume":"272","author":"DF Tough","year":"1996","unstructured":"Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 1996;272:1947\u201350.","journal-title":"Science"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/intimm\/11.9.1463","volume":"11","author":"SO Andreasen","year":"1999","unstructured":"Andreasen SO, Christensen JP, Marker O, Thomsen AR. Virus-induced non-specific signals cause cell cycle progression of primed CD8 (+) T cells but do not induce cell differentiation. Int Immunol. 1999;11:1463\u201373.","journal-title":"Int Immunol"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"37882","DOI":"10.18632\/oncotarget.9352","volume":"7","author":"J Nie","year":"2016","unstructured":"Nie J, Zhang Y, Li X, Chen M, Liu C, Han W. DNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire. Oncotarget. 2016;7:37882\u201392.","journal-title":"Oncotarget"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-017-0001-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-017-0001-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-017-0001-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T06:47:09Z","timestamp":1659077229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-017-0001-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,29]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1038\/s41434-017-0001-8","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,29]]},"assertion":[{"value":"15 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}